Citation Impact
Citing Papers
Treatment Response Assessment in IDH-Mutant Glioma Patients by Noninvasive 3D Functional Spectroscopic Mapping of 2-Hydroxyglutarate
2015 StandoutNobel
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
2015 Standout
Differential diagnosis of suspected multiple sclerosis: a consensus approach
2008
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
2005 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Parkinson-like syndrome induced by continuous MPTP infusion: Convergent roles of the ubiquitin-proteasome system and α-synuclein
2005 StandoutNobel
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
2008 StandoutNature
Why do cancers have high aerobic glycolysis?
2004 Standout
Genetic and hypoxic regulation of angiogenesis in gliomas
2004
Positron emission tomography11C-methionine and survival in patients with low-grade gliomas
2001
PET in clinical oncology
1988
Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines
2006 Standout
Leptin induces migration and invasion of glioma cells through MMP‐13 production
2008
The spectrum of neuromyelitis optica
2007 Standout
Formation and Removal of α-Synuclein Aggregates in Cells Exposed to Mitochondrial Inhibitors
2002
The role of α-synuclein in Parkinson's disease: insights from animal models
2003
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis
2006 Standout
The Roles of PINK1, Parkin, and Mitochondrial Fidelity in Parkinson’s Disease
2015 Standout
Malignant astrocytic glioma: genetics, biology, and paths to treatment
2007 Standout
A Novel Volume-Age-KPS (VAK) Glioblastoma Classification Identifies a Prognostic Cognate microRNA-Gene Signature
2012
Epidemiology of Parkinson's disease
2006 Standout
A comparative study of thallium-201 SPET, carbon-11 methionine PET and fluorine-18 fluorodeoxyglucose PET for the differentiation of astrocytic tumours
1998
Multiple sclerosis
2008 Standout
Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease
2001 StandoutNobel
Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease
1997
Fluorescent and colorimetric probes for detection of thiols
2010 Standout
Guidelines on management of low‐grade gliomas: report of an EFNS–EANO* Task Force
2010
Origin and functional consequences of the complex I defect in Parkinson's disease
1996
Development, maintenance and disruption of the blood-brain barrier
2013 Standout
‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease?*
2003 Standout
Oxidative stress in Parkinson's disease
2003 Standout
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
2011 Standout
Parkinson's Disease
1998 Standout
Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases
2006 StandoutNature
Primary brain tumours in adults
2012 Standout
Autophagy in cell death: an innocent convict?
2005 Standout
Progressive necrotizing myelopathy: part of the spectrum of neuromyelitis optica?
2006
Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies
2002
Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies
2006 Standout
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
2000 Standout
Modes of resistance to anti-angiogenic therapy
2008 Standout
The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia
2003 Standout
Active-site directed irreversible inhibition of diamine oxidase by a homologous series of aziridinylalkylamines
1992
Cholesterol crystal embolism: A recognizable cause of renal disease
2000
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
2004 Standout
Brain Tumors
2001 Standout
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
2005 Standout
Parkinson's Disease
2003 Standout
Molecular Definition of Chromosome Translocations Involving 10q24 and 19q13 in Human Malignant Glioma Cells
1998
Hypoxia imaging in brain tumors
2002
Neuromyelitis optica diagnosis in clinically isolated syndromes suggestive of multiple sclerosis
2006
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
The 2007 WHO Classification of Tumours of the Central Nervous System
2007 Standout
Homocysteine, MTHFR 677C→T polymorphism, and risk of ischemic stroke
2002
Familial multisystem degeneration with parkinsonism associated with the 11778 mitochondrial DNA mutation
1999
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Neuromyelitis optica with hypothalamic involvement
2005
Revised diagnostic criteria for neuromyelitis optica
2006 Standout
Simultaneous determination of methionine and total homocysteine in human plasma by gas chromatography–mass spectrometry
2001
Cortical anomalies in brains of New Zealand mice: a neuropathologic model of dyslexia?
1985
Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patients.
2001
Distinct Role for Microglia in Rotenone-Induced Degeneration of Dopaminergic Neurons
2002 Standout
Copper Homeostasis and Neurodegenerative Disorders (Alzheimer's, Prion, and Parkinson's Diseases and Amyotrophic Lateral Sclerosis)
2006 Standout
Use of Transmitochondrial Cybrids To Assign a Complex I Defect to the Mitochondrial DNA-Encoded NADH Dehydrogenase Subunit 6 Gene Mutation at Nucleotide Pair 14459 That Causes Leber Hereditary Optic Neuropathy and Dystonia
1996
Klebsiellaspp. as Nosocomial Pathogens: Epidemiology, Taxonomy, Typing Methods, and Pathogenicity Factors
1998 Standout
Mitochondrial Diseases in Man and Mouse
1999 StandoutScience
The Prognostic Significance of Phosphatidylinositol 3-Kinase Pathway Activation in Human Gliomas
2004
Specification of Cerebral Cortical Areas
1988 StandoutScience
Role of Extent of Resection in the Long-Term Outcome of Low-Grade Hemispheric Gliomas
2008
The 2007 WHO Classification of Tumours of the Central Nervous System
2010 Standout
Type 3 fimbriae among enterobacteria and the ability of spermidine to inhibit MR/K hemagglutination
1989
Recommendations for Imaging of Acute Ischemic Stroke
2009
Astrocyte-specific expression of activated p21-ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomas.
2001
Methylation of hypoxia-inducible factor (HIF)-1α by G9a/GLP inhibits HIF-1 transcriptional activity and cell migration
2018 StandoutNobel
Prognostic Effect of Epidermal Growth Factor Receptor and EGFRvIII in Glioblastoma Multiforme Patients
2005
Devic’s neuromyelitis optica: a critical review
2008
An Updated Definition of Stroke for the 21st Century
2013 Standout
NMO-IgG and Devic's neuromyelitis optica: a French experience
2008
Oligodendrogliomas result from the expression of an activated mutant epidermal growth factor receptor in a RAS transgenic mouse astrocytoma model.
2003
BOTANICAL INSECTICIDES, DETERRENTS, AND REPELLENTS IN MODERN AGRICULTURE AND AN INCREASINGLY REGULATED WORLD
2005 Standout
Phosphorylation Meets Ubiquitination: The Control of NF-κB Activity
2000 Standout
Medullomyoblastoma. A histologic, immunohistochemical, and ultrastructural study
1984
Mitochondrial dysfunction in Parkinson's disease
1999
Metals in Neurobiology: Probing Their Chemistry and Biology with Molecular Imaging
2008 Standout
Oxidative stress in neurodegeneration: cause or consequence?
2004 Standout
Works of M. Chatel being referenced
Total plasma homocysteine determination by liquid chromatography before and after methionine loading
1997
Cytogenetics of malignant gliomas: I. The autosomes with reference to rearrangements
1995
Mitochondrial respiratory failure in skeletal muscle from patients with Parkinson's disease and multiple system atrophy
1994
[11C]L-methionine uptake in gliomas
1989
Expression of vascular endothelial growth factor-b in humanastrocytoma
2000
Early <sup>99m</sup>Tc-Ethylcysteinate Dimer Brain SPECT Patterns in the Acute Phase of Stroke as Predictors of Neurological Recovery
2000
Insulin-like growth factor type I biology and targeting in malignant gliomas
2007
Is Devic's neuromyelitis optica a separate disease? A comparative study with multiple sclerosis
2003
The antitumoral action of polyamine linked cyclophosphazenes on human malignant glioma heterografts in nu/nu mice.
1991
Epidermal growth factor receptor and labeling index are independent prognostic factors in glial tumor outcome.
1998
[11C]l-Methionine Uptake in Gliomas
1989
Neural differentiation in the OTT-6050 mouse teratoma
1981
[Development of the isocortex of the human brain during the embryonic and fetal periods up to the 24th week of gestation].
1976
Long-term outcome of oligodendrogliomas
2004
Brain tumor protein synthesis and histological grades: A study by positron emission tomography (PET) with C11-L-Methionine
1986
Red blood cell polyamines as biochemical markers of supratentorial malignant gliomas.
1987
[Cholesterol emboli with neurologic manifestation in the spinal cord].
1992